What are the normal prothrombin time (PT) and international normalized ratio (INR) values for a newborn?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Normal PT/INR Values in Neonates

Newborns have physiologically prolonged PT and elevated INR values compared to adults, with baseline INR values typically ranging from 1.0-1.3 at birth, and vitamin K-dependent coagulation factors naturally decreased to levels comparable to adults on therapeutic anticoagulation (INR 2.0-3.0). 1

Physiologic Baseline Values

The coagulation system in neonates differs fundamentally from adults due to developmental hemostasis. Plasma levels of vitamin K-dependent coagulation factors are physiologically decreased in newborns, creating baseline values that would be considered abnormal in adults 1.

Specific Reference Ranges by Age

Recent research provides gestational age-specific reference intervals 2:

For term neonates (GA 37-39 weeks):

  • PT: 33-61%
  • INR: 1.1-1.7
  • APTT: 28-43 seconds

For term neonates (GA 40-42 weeks):

  • PT: 30-65%
  • INR: 1.2-1.8
  • APTT: 24-38 seconds

Point-of-care testing in healthy 4-day-old term neonates shows median INR of 1.10 with range 0.90-1.30 3. Another study found aPTT reference range of 28.6-46.2 seconds and PT of 71.3-110.6 seconds in infants up to 3 months 4.

Critical Clinical Implications

Why These Values Matter

The physiologically elevated INR in neonates creates several important clinical considerations:

  • Warfarin dosing protocols start with baseline INR of 1.0-1.3 as the reference point 1
  • Infants require higher weight-based warfarin doses (average 0.33 mg/kg) compared to teenagers (0.09 mg/kg) to maintain therapeutic INR 2.0-3.0 1
  • Breast milk contains virtually no vitamin K (0.3 μg/100 kcal) versus formula (8-16 μg/100 kcal), making breastfed infants extremely sensitive to vitamin K antagonists 5

Important Caveats

The INR was designed and validated exclusively for monitoring vitamin K antagonist therapy in adults - it is not validated for assessing bleeding risk in neonates not on anticoagulation 6. Using adult INR targets to guide plasma transfusion or predict bleeding in neonates is inappropriate and lacks evidence 6.

Reagent and Analyzer Specificity

Reference ranges are highly dependent on the specific reagent and analyzer used 7. Using published reference ranges requires identical analyzer and reagent systems - approximately 30% of children aged 1-5 years would be misclassified as abnormal if adult reference ranges were applied 7.

Developmental Changes

Coagulation parameters change rapidly during the first months of life as the hemostatic system matures 5. PT and INR values in neonates do not correlate significantly with age or weight in the first 3 months 4, but the vitamin K-dependent factors gradually increase toward adult levels over the first year 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.